The outlook of companies tied to iconic drugs like Viagra presents a challenging investment landscape . While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial returns, the loss of exclusivity in key markets has introduced substantial risk . Investors are now grappling with the impact of rival medica